Pathstone Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Sell |
336,697
-35,034
| -9% | -$2.45M | 0.09% | 145 |
|
|
2025
Q1 | $27.3M | Buy |
371,731
+1,502
| +0.4% | +$110K | 0.12% | 130 |
|
|
2024
Q4 | $24.3M | Buy |
370,229
+22,995
| +7% | +$1.51M | 0.11% | 129 |
|
|
2024
Q3 | $27.1M | Buy |
347,234
+11,703
| +3% | +$912K | 0.12% | 123 |
|
|
2024
Q2 | $26.2M | Buy |
335,531
+5,929
| +2% | +$462K | 0.12% | 126 |
|
|
2024
Q1 | $22.3M | Buy |
329,602
+116,985
| +55% | +$7.93M | 0.1% | 132 |
|
|
2023
Q4 | $14.3M | Buy |
+212,617
| New | +$14.3M | 0.08% | 192 |
|